About Sosei Group
Sosei Group Corporation is an international biopharmaceutical company originating from Japan that discovers and develops innovative biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic disease, and other indications. By utilizing our platform technologies - GPCR structure-based drug design platform technology, peptide platform technologies and nanotechnology - we have established a product pipeline with first/best in class potential.
Through development and commercialization partnerships we have already delivered three medicines to the market (two COPD bronchodilators and an emergency contraceptive), which generate significant and stable revenue streams that enable further growth. Our partners include Novartis, AstraZeneca, MedImmune, Cubist, MorphoSys, Takeda and we are actively looking for new partnerships to enhance the development of our products and help us deliver them to patients worldwide.